Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial
. More than 70,000 people died of drug overdoses in 2017 alone, with 68% of the fatalities involving prescription or illicit opioids.accusing the company of fueling the opioid crisis. The drugmaker was ordered to pay a $572 million fine, a sum that fell well under the more than $17 billion sought by the state.
Oxycontin producer Purdue Pharma folded in September after lawsuits pushed the company to file for bankruptcy protection. The company's settlement costs could breach $12 billion over time,J&J has 12 "buy" ratings, 11 "hold" ratings, and one "sell" rating from analysts, with a consensus price target of $148.53, according to Bloomberg data.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Johnson & Johnson settles Ohio lawsuits to avoid federal trialJohnson & Johnson to pay $20.4 million to settle opioid lawsuits with two Ohio counties
Weiterlesen »
Johnson & Johnson settles with Ohio counties for $20 million prior to opioid trialJohnson & Johnson has agreed to a $20.4M settlement with two Ohio counties in an effort to avoid a lengthy and costly federal trial about the opioid addiction epidemic.
Weiterlesen »
Johnson & Johnson Agrees to Settle Ohio Opioid Lawsuits for $20.4 MillionJohnson & Johnson said it has agreed to a $20.4 million deal to avoid an upcoming trial accusing the company of helping spark an opioid-addiction crisis in two Ohio counties.
Weiterlesen »